HYPERION THERAPEUTICS INC — Form D

HYPERION THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-18. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Bo Jesper I HansenDirectorBrisbane, CA
James I HealyDirectorDORADO, PR
Jake R NunnDirectorSan Diego, CA
Bijan R SalehizadehDirectorChicago, IL
Daniel G WelchDirectorBrisbane, CA
Lota S ZothDirectorLa Jolla, CA
Klara A DickinsonExecutive OfficerBrisbane, CA
Jeffrey S FarrowExecutive OfficerBrisbane, CA
Ashley A GouldExecutive OfficerBrisbane, CA
Natalie A HollesExecutive OfficerBrisbane, CA
CHRISTINE A NASHExecutive OfficerNEW HAVEN, CT
Donald J SantelExecutive OfficerSan Diego, CA
Bruce F ScharschmidtExecutive OfficerBrisbane, CA
Gaurav AggarwalDirectorPalo Alto, CA
Rob HopfnerDirectorSan Diego, CA
Robert HopfnerDirectorPalo Alto, CA
James HealyDirectorSunnyvale, CA
Daniel PerezDirectorSan Francisco, CA
David GryskaDirectorDallas, TX
Donald SantelDirectorSan Diego, CA
Donald SantelExecutive OfficerSan Diego, CA
Bijan SalehizadehDirectorBETHESDA, MD
Jake NunnDirectorMenlo Park, CA
Bo Jesper HansenDirectorWestlake Village, CA
Christine NashExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2011-11-04D$15.0M$7.5M
2011-04-18D$35.0M$17.5M
2009-07-16D$45.5M$22.0M
2009-05-14D$15.0M$13.0M

More